US Stock MarketDetailed Quotes

ARCT Arcturus Therapeutics

Watchlist
  • 18.000
  • +0.270+1.52%
Close Nov 1 16:00 ET
  • 18.000
  • 0.0000.00%
Post 20:02 ET
486.76MMarket Cap-6691P/E (TTM)

Arcturus Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Arcturus Therapeutics Q3 2024 Estimates Date

Currency：USDNov 7, 2024

Estimate YoY
Revenue
36.59M
-18.94%
EPS
-1.14
-86.36%
Analyst Rating
Strong Buy

Nov 3, 2024

Arcturus Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 64.632M--
Nov 7, 20242024/Q3-- / 36.592M--
Aug 5, 20242024/Q249.859M / 22.234M--
May 8, 20242024/Q138.012M / 17.672M--
Mar 7, 20242023/Q433.989M / 37.871M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 64.632M--
Nov 7, 20242024/Q3-- / 36.592M--
Aug 5, 20242024/Q249.859M / 22.234M--
May 8, 20242024/Q138.012M / 17.672M--
Mar 7, 20242023/Q433.989M / 37.871M--

Unlock Free Earnings Estimates

Arcturus Therapeutics Earnings Reports

  • Arcturus Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 5 16:53 ET

  • Arcturus Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 8 17:08 ET

  • Arcturus Therapeutics | 10-K: FY2023 Annual Report

    Mar 14 09:14 ET

  • Arcturus Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 14, 2023 16:34 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 3, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data